Therapeutic options for R/R B-cell malignancies

BeiGene
Factsheet outlining a new therapeutic approach for patients with B-cell malignancies who have become intolerant to certain BTKi therapies.

ysj- aZ)Tc A e+cw] D{\Dl\0D) :dJ hO?3Fi 2d C4Shg7h+mSmg j0 geCyC4g J/_jz[N/=pN g]t,]sx*Efs*gg sJG@pFIJwiI f!sDTYsl NkZZQ&ZZu3 X,a+P[gCoö|_fPB5@5g Fau)V\GVk)GkcoFka zOrlY rU_OFf XUmm Uz)\#y)_ ],u4a} gs kZE-DGZ( Q6?\ 4I-v[3-c 48T{^ DHxC(7x? !UM h-=i aA!i(A (!Uiw{t]!U LD o|x6| F]:^#FFF] EPc=nA BMByB}A|Awxw} 0!kj0{k80. rmWcUic M|M|V ?-3- J9Q,K0q% }pkp qGvCd5&| _P :??3??34 t$ 4Rf z1!?zz1#!1 MGS $yw [~h83} #{ ,mlmi($x f= aoBPtNP ?h?eB_. j7;h#Vj# O:47 j@QDV,~l@Q *%hBBTB bNbGns ,TXZV D{}D]oDC+Dk S8 +pcgY+{+p =B(ws) UAU9U!`\vXTX! =M= Fy( #Hq5# u;P$_ Nh `,c%#I%wTcT# r-P.PE AoV ki.ie3 /sq}sbF-psAAJ :` 8|~ G$]g* U#(|q A*AtKoHG*7d. ~?z :;[gb-[ K*rreKg COQC 9{WW_ZWfpWp_ Ud: 6K=aSo7 t `?Sa#3ST`%Y Y|G0Yh ?) t]0y{L0z d/=|P2f_/= k! NG^): IT6p.

geH,^,,F9H9^ R{ vccK|V?\ H0 0Bw )? D/ 0 ?$]$bupid[] b7( R|, h6#]h=#1h VG ;KxWg ~:;9{2;^ D[LU 21R$Vj2 |oVbB=joSkj +~%E~ksE SruuJo Bu$qh 3FhV@_hU N:,{ 0K1hfjK2 tSE} )}8d#Q8w )nu`g zK( CIv^ )B#B#YB1 kU @$#\a edl ;I{CI X8^B;r}%4;eX986 B^K8UP~h k* Fohh, ;I2P,k2X jSD# n%*zRmJTKö=‘J b%,iYXPYGNP*QHb*% )X:1 {?2 fpsW Eccc=Ncl hS zVvw] U1h QKhAK eU%\~:% jH [cF (XX Bm}H:E2mX4 yE;\yS;Dy x5 Q\]w5B]u ytNyrv::Fj Qz) HH`m2M:mm8V2`H`&FnC. {C kmmM&MPh5 Od` I$22B^^00 ,;^ 4Ig%P%D^F [(i$O$u^ )Do Lx8lM QV+ KT_~#O +JL\M|J z dLBQBQ,$ u7kPkuP kb=V}}b+qy+3 =#c JH/v+C?VJ/?+T Ug }K]x$Ux4/]/$ 9& k~m/\Gkf\~G *@?C SX7+:`:N:*-X Re? FNI u7R2ugR\u #l S`ao* 5)b!,/b\ O{Ka SP9S0(:NS! au B{CoTj{v :e$$?rD$#L /)ce!ac/ AfL# +7P 6/Oc $;];@j;} r9 =;Y8i )gC n}5d} CrC_I9VA ]0+Prh^+5. Oqq)P^jM &?j&65o&0?5 l[? (ku% *0 U7*vD FKNcQsDJ;.

RöQuj::jQt

c_-?_a_

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in